Open in TheBrain

Carbapenem

Carbapenems are a class of highly effective antibiotics used in the treatment of severe or high-risk bacterial infections. They belong to the beta-lactam family, which also includes penicillins and cephalosporins. Known for their broad-spectrum activity, carbapenems are often reserved for infections caused by multi-drug resistant bacteria.

Mechanism of Action

Carbapenems work by inhibiting bacterial cell wall synthesis. They bind to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, disrupting the construction of the wall and leading to cell lysis and death. This mechanism is similar to other beta-lactam antibiotics, but carbapenems are more resistant to beta-lactamase enzymes produced by some bacteria to inactivate these drugs.

Types of Carbapenems

There are several carbapenems available for clinical use, each with unique properties:

  1. Imipenem: Often combined with cilastatin to prevent its degradation in the kidneys.
  2. Meropenem: Known for its effectiveness against a wide range of bacteria, including Pseudomonas aeruginosa.
  3. Ertapenem: Has a longer half-life, allowing for once-daily dosing, but is less effective against Pseudomonas and Acinetobacter species.
  4. Doripenem: Similar to meropenem, with strong activity against Gram-negative bacteria.

Clinical Uses

Carbapenems are used to treat a variety of infections, including:

Due to their broad-spectrum activity, carbapenems are often used as a last resort when other antibiotics fail.

Resistance Concerns

The emergence of carbapenem-resistant organisms is a significant public health concern. Resistance mechanisms include:

Carbapenem-resistant Enterobacteriaceae (CRE) are particularly concerning due to their ability to spread resistance genes to other bacteria.

Strategies to Combat Resistance

Efforts to combat carbapenem resistance include:

Side Effects and Considerations

While carbapenems are generally well-tolerated, they can cause side effects such as:

It is crucial to monitor patients for these adverse effects and adjust treatment as necessary.

Carbapenems and aminoglycosides exposure are likely risk factors for carbapenem-resistant Klebsiella pneumoniae infection.

Attachments